| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy
|
Schindler, U.
|
|
2018
|
92 |
S1 |
p. S14-S15
|
artikel
|
| 2 |
AB680, a potent and selective CD73 small molecule inhibitor, reverses the AMP/adenosine-mediated impairment of immune effector cell activation by immune checkpoint inhibitors
|
Schindler, U.
|
|
2018
|
92 |
S1 |
p. S14
|
artikel
|
| 3 |
Altered type III collagen turnover measured in pre-treatment serum predicts outcome in metastatic melanoma patients treated with Ipilimumab
|
Jensen, C.
|
|
2018
|
92 |
S1 |
p. S7
|
artikel
|
| 4 |
A new combination immunotherapy approach with anti-PD-L1 and HER2/neu loaded dendritic cell vaccine along with saponin adjuvant
|
Ozverel, C.S.
|
|
2018
|
92 |
S1 |
p. S6-S7
|
artikel
|
| 5 |
A new family of potent TLR9 agonists, EnanDIM, which inhibit tumor growth in various syngeneic murine models
|
Volz, B.
|
|
2018
|
92 |
S1 |
p. S5-S6
|
artikel
|
| 6 |
A novel rMVA combination immunotherapy triggers potent innate and adaptive immune responses against established tumors
|
Medina, J.
|
|
2018
|
92 |
S1 |
p. S24
|
artikel
|
| 7 |
Arming T cells with activating FcγRIIIa receptors for antibody redirected lysis of cancer cells
|
Jacobi, S.J.
|
|
2018
|
92 |
S1 |
p. S21
|
artikel
|
| 8 |
Author index
|
|
|
2018
|
92 |
S1 |
p. I-II
|
artikel
|
| 9 |
Breast cancer immunotherapy using magnetised oncolytic viruses
|
AL-Janabi, H.
|
|
2018
|
92 |
S1 |
p. S4
|
artikel
|
| 10 |
Building Kras (G12D)/Trp53 null/Pdx1-cre (KPC) mouse allograft tumor model for efficacy evaluation of combinatory immunotherapie
|
Song, Y.
|
|
2018
|
92 |
S1 |
p. S6
|
artikel
|
| 11 |
Cancer cells regulate Interleukin-22 production to promote tumor growth
|
Voigt, C.
|
|
2018
|
92 |
S1 |
p. S8
|
artikel
|
| 12 |
CD73 activity and outcome of advanced melanoma patients treated with nivolumab
|
Morello, S.
|
|
2018
|
92 |
S1 |
p. S22
|
artikel
|
| 13 |
Circulating regulatory T-cells and the clinical outcome of VEGF-targeted treatment of metastatic colorectal cancer patients: focused on KRAS status and primary tumour sidedness
|
Zdrazilova-Dubska, L.
|
|
2018
|
92 |
S1 |
p. S1-S2
|
artikel
|
| 14 |
Complete clinical remission of stage IV breast cancer with liver, lung, bone and lymph node metastasis combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia and metronomic low-dose chemotherapy
|
Kleef, R.
|
|
2018
|
92 |
S1 |
p. S13
|
artikel
|
| 15 |
Cytokine-Induced Killer cells combined with anti EGFR monoclonal antibody abrogate triple negative breast cancer metastatization
|
Sommaggio, R.
|
|
2018
|
92 |
S1 |
p. S20
|
artikel
|
| 16 |
Depletion of MDSC improves the anti-neuroblastoma effect of adoptive recipient leukocyte infusion in allogeneic bone marrow transplanted mice
|
Dierckx de Casterlé, I.
|
|
2018
|
92 |
S1 |
p. S20-S21
|
artikel
|
| 17 |
Determining tumor mutation load using an NGS-based, target gene panel
|
Machado, J.C.
|
|
2018
|
92 |
S1 |
p. S4-S5
|
artikel
|
| 18 |
Digital spatial profiling platform allows for spatially-resolved, multiplexed measurement of solid tumor protein distribution and abundance in FFPE tissue sections
|
Winfield, A.
|
|
2018
|
92 |
S1 |
p. S9
|
artikel
|
| 19 |
Eliciting protective T cell immunity against EBV-associated malignancies by vaccination
|
Rühl, J.
|
|
2018
|
92 |
S1 |
p. S19
|
artikel
|
| 20 |
Engineering high affinity, soluble T cell receptors for the treatment of cancer
|
Holt, L.
|
|
2018
|
92 |
S1 |
p. S15-S16
|
artikel
|
| 21 |
Enhancing Cytokine-Induced Killer (CIK) cell activity with Her2-specific Fc-engineered antibodies and antibody derivatives
|
Cappuzzello, E.
|
|
2018
|
92 |
S1 |
p. S23-S24
|
artikel
|
| 22 |
Exploring phenotypic and functional characteristics of cultured tumor infiltrating lymphocytes
|
Rana, M.
|
|
2018
|
92 |
S1 |
p. S24
|
artikel
|
| 23 |
Expression of CD73 on MDSCs and CD8+/PD-1+ cells as new possible biomarkers for advanced melanoma patients treated with nivolumab
|
Fratangelo, F.
|
|
2018
|
92 |
S1 |
p. S24-S25
|
artikel
|
| 24 |
GARP-TGFβ axis on activated platelets supports tumor progression
|
Metelli, A.
|
|
2018
|
92 |
S1 |
p. S3
|
artikel
|
| 25 |
HAGE-derived peptide as a vaccine to prevent relapse in TNBC patients: Proof of concepts
|
Nagarajan, D.
|
|
2018
|
92 |
S1 |
p. S18
|
artikel
|
| 26 |
How cancer specific T-cell recognition and functionality is affected by combination of radio- and immunotherapeutic strategies
|
Meldgaard, T.S.
|
|
2018
|
92 |
S1 |
p. S21
|
artikel
|
| 27 |
Humanized mouse models of triple-negative and triple-positive breast cancer for preclinical validation of novel immuno-oncology therapies
|
Kähkönen, T.E.
|
|
2018
|
92 |
S1 |
p. S7-S8
|
artikel
|
| 28 |
Immune landscape analysis to identify targets for immunotherapy across human carcinomas
|
Schnappinger, J.
|
|
2018
|
92 |
S1 |
p. S1
|
artikel
|
| 29 |
Immune modulation of AML-blasts in therapy-refractory AML-patient in vivo with clinically approved response modifiers improves clinical status, blood cell regeneration and gives rise to leukemia specific adaptive and innate immune reactive cells
|
Schmid, C.
|
|
2018
|
92 |
S1 |
p. S15
|
artikel
|
| 30 |
Immuno-related adverse events from check-point inhibitors during immune-therapy for cancer. Imaging findings
|
Sandomenico, F.
|
|
2018
|
92 |
S1 |
p. S22
|
artikel
|
| 31 |
Impact of natural substances on the efficacy of immunotherapy
|
Luzbetak, M.
|
|
2018
|
92 |
S1 |
p. S17
|
artikel
|
| 32 |
Insights into the tumor microenvironment and human TRBV gene polymorphism revealed by long-amplicon immune repertoire sequencing
|
Lowman, G.M.
|
|
2018
|
92 |
S1 |
p. S11
|
artikel
|
| 33 |
In vitro culture of tumor infiltrating lymphocytes for adoptive immunotherapy in breast cancer patients
|
Seber, S.
|
|
2018
|
92 |
S1 |
p. S9-S10
|
artikel
|
| 34 |
Keyword Index
|
|
|
2018
|
92 |
S1 |
p. III
|
artikel
|
| 35 |
Local oncothermia (modulated-electrohyperthermia) against systemic malignancy
|
Szasz, A.
|
|
2018
|
92 |
S1 |
p. S14
|
artikel
|
| 36 |
Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models
|
Benmebarek, M.
|
|
2018
|
92 |
S1 |
p. S20
|
artikel
|
| 37 |
MiRNA set dysregulation in breast cancer cells can contribute to both primary and acquired resistance to immune checkpoint blockade
|
Halytskiy, V.A.
|
|
2018
|
92 |
S1 |
p. S13
|
artikel
|
| 38 |
M1 polarization of tumor-associated macrophages after irradiation of human rectal cancer in patients and 3D co-culture model
|
Stary, V.
|
|
2018
|
92 |
S1 |
p. S25
|
artikel
|
| 39 |
Novel PAP-derived vaccine for the treatment of advanced prostate cancer
|
Le Vu, P.
|
|
2018
|
92 |
S1 |
p. S18
|
artikel
|
| 40 |
Omental fat in ovarian cancer induces lymphangiogenesis
|
Ferber, D.
|
|
2018
|
92 |
S1 |
p. S8
|
artikel
|
| 41 |
Omental fat in ovarian cancer induces metabolic and immune alterations
|
Suarez-Carmona, M.
|
|
2018
|
92 |
S1 |
p. S3
|
artikel
|
| 42 |
Orthotopic HCC mouse models to predict response to immunotherapy
|
Hage, C.
|
|
2018
|
92 |
S1 |
p. S5
|
artikel
|
| 43 |
Peritumoral gene electrotransfer of interleukin-12 as an adjuvant immunotherapy to intratumoral electrochemotherapy for murine melanoma treatment
|
Ursic, K.
|
|
2018
|
92 |
S1 |
p. S16-S17
|
artikel
|
| 44 |
P-MAPA immunotherapy and interleukin-12 on ovarian carcinoma SKOV-3 cells: Assessment of the TLR signaling and cytokine/chemokine profile
|
Chuffa, L.
|
|
2018
|
92 |
S1 |
p. S17
|
artikel
|
| 45 |
Positive controls for cytometric in vitro T cell activation test for bladder carcinoma patient stratification and monitoring
|
Hadlova, P.
|
|
2018
|
92 |
S1 |
p. S22-S23
|
artikel
|
| 46 |
Preclinical characterization of a PD-1-CD28 fusion receptor in CD4+ T cells for T cell-based immunotherapy of pancreatic cancer and Non-Hodgkin Lymphoma
|
Rataj, F.
|
|
2018
|
92 |
S1 |
p. S4
|
artikel
|
| 47 |
Preclinical development of a therapeutic antibody for the treatment of epithelial ovarian carcinoma
|
Suarez-Carmona, M.
|
|
2018
|
92 |
S1 |
p. S6
|
artikel
|
| 48 |
Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors
|
Karches, C.
|
|
2018
|
92 |
S1 |
p. S19
|
artikel
|
| 49 |
4SC-202 increases immunogenicity of tumor cells, induces infiltration of tumor microenvironment with cytotoxic T cells, and primes tumors for cancer immunotherapy
|
Hamm, S.
|
|
2018
|
92 |
S1 |
p. S16
|
artikel
|
| 50 |
Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in early stage NSCLC patients
|
Gamerith, G.
|
|
2018
|
92 |
S1 |
p. S12
|
artikel
|
| 51 |
Spatial profiling and functional phenotyping of mast cell distribution in human cancer tissues
|
Ferber, D.
|
|
2018
|
92 |
S1 |
p. S8-S9
|
artikel
|
| 52 |
Standard normoxic versus physiological hypoxic culture of AML patients' (pts) whole blood (WB) samples with immune modulatory kits yields comparable proportions of dendritic cells and functional results
|
Doraneh gard, F.
|
|
2018
|
92 |
S1 |
p. S10-S11
|
artikel
|
| 53 |
Table of Content
|
|
|
2018
|
92 |
S1 |
p. iv
|
artikel
|
| 54 |
The adjuvant effect of melanin is superior to Incomplete Freund adjuvant in a tumor subunit vaccine model
|
Carpentier, A.F.
|
|
2018
|
92 |
S1 |
p. S2-S3
|
artikel
|
| 55 |
The influence of stromal cells on CD3+ CD8+ tumor infiltrating lymphocyte subpopulations in cancer microtissues
|
Koeck, S.
|
|
2018
|
92 |
S1 |
p. S12
|
artikel
|
| 56 |
The role of myeloid-derived suppressor cells in autologous hematopoietic stem cell transplantation
|
Betsch, A.
|
|
2018
|
92 |
S1 |
p. S10
|
artikel
|
| 57 |
The role of Topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer
|
Gamea, M.M.
|
|
2018
|
92 |
S1 |
p. S12-S13
|
artikel
|
| 58 |
The use of EGFR-CD3 bispecific antibody and antigen-specific high avidity T cells to target cancer associated fibroblasts and cancer cells within a melanoma organoid system
|
Reddy, N.
|
|
2018
|
92 |
S1 |
p. S2
|
artikel
|
| 59 |
Trends in incidence of head and neck cancers in India
|
Francis, D.
|
|
2018
|
92 |
S1 |
p. S23
|
artikel
|
| 60 |
Tumor-specific neoantigens drive T-cell clonotype convergence
|
Machado, J.C.
|
|
2018
|
92 |
S1 |
p. S11
|
artikel
|
Tijdschrift beschrijving